The economic impact, healthcare resource utilization, and clinical outcome over 24 months in patients with relapsing-remitting multiple sclerosis treated with dimethyl fumarate in Greece- The Fidelity Study
The economic impact, healthcare resource utilization, and clinical outcome over 24 months in patients with relapsing-remitting multiple sclerosis treated with dimethyl fumarate in Greece- The Fidelity Study
Georgia Kourlaba, Christos Bakirtzis, G. Karachalios, Georgios Koutsis et al.
Journal
Expert Review of Pharmacoeconomics & Outcomes Research
Topics
Multiple Sclerosis Research Studies
article
The economic impact, healthcare resource utilization, and clinical outcome over 24 months in patients with relapsing-remitting multiple sclerosis treated with dimethyl fumarate in Greece- The Fidelity Study
Georgia Kourlaba, Christos Bakirtzis, G. Karachalios, Georgios Koutsis, Vana Tsimourtou, Nikolaos Fakas, Nikolaos Girgoriadis
article en
Abstract
No abstract available for this paper.
Publication Tag
Expert Review of Pharmacoeconomics & Outcomes ResearchVol. 26(2)
Institutions
University of Peloponnese (GR), National and Kapodistrian University of Athens (GR), Aristotle University of Thessaloniki (GR), 401 General Military Hospital of Athens (GR), University Hospital of Larissa (GR), Genesis Medical Center (US)